Kovack Advisors Inc. Has $1.83 Million Stock Position in Axon Enterprise, Inc $AXON

Kovack Advisors Inc. trimmed its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 40.0% during the third quarter, Holdings Channel.com reports. The institutional investor owned 2,545 shares of the biotechnology company’s stock after selling 1,699 shares during the quarter. Kovack Advisors Inc.’s holdings in Axon Enterprise were worth $1,826,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of AXON. New Millennium Group LLC bought a new position in Axon Enterprise during the third quarter worth $29,000. BIT Capital GmbH boosted its position in shares of Axon Enterprise by 75.6% during the 3rd quarter. BIT Capital GmbH now owns 3,535 shares of the biotechnology company’s stock worth $2,537,000 after purchasing an additional 1,522 shares in the last quarter. Y.D. More Investments Ltd grew its stake in shares of Axon Enterprise by 28.0% in the 3rd quarter. Y.D. More Investments Ltd now owns 96 shares of the biotechnology company’s stock valued at $69,000 after buying an additional 21 shares during the period. Persistent Asset Partners Ltd bought a new stake in Axon Enterprise in the 3rd quarter valued at about $718,000. Finally, Prakash Investment Advisors LLC raised its stake in Axon Enterprise by 128.3% during the 3rd quarter. Prakash Investment Advisors LLC now owns 5,250 shares of the biotechnology company’s stock worth $3,768,000 after buying an additional 2,950 shares during the period. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Trading Up 2.6%

NASDAQ AXON opened at $441.12 on Friday. The company has a debt-to-equity ratio of 0.57, a current ratio of 3.12 and a quick ratio of 2.89. The stock has a market capitalization of $34.81 billion, a price-to-earnings ratio of 139.60, a PEG ratio of 12.96 and a beta of 1.48. Axon Enterprise, Inc has a one year low of $396.41 and a one year high of $885.91. The business’s fifty day moving average is $547.24 and its 200-day moving average is $640.09.

Insider Transactions at Axon Enterprise

In other news, CFO Brittany Bagley sold 2,000 shares of the stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $580.00, for a total transaction of $1,160,000.00. Following the completion of the transaction, the chief financial officer owned 103,501 shares in the company, valued at approximately $60,030,580. This represents a 1.90% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Jeri Williams sold 100 shares of the company’s stock in a transaction dated Thursday, December 4th. The shares were sold at an average price of $550.63, for a total transaction of $55,063.00. Following the sale, the director directly owned 1,316 shares in the company, valued at approximately $724,629.08. This trade represents a 7.06% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 48,040 shares of company stock valued at $27,249,338. 4.40% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several research firms have recently commented on AXON. Wall Street Zen downgraded Axon Enterprise from a “hold” rating to a “sell” rating in a report on Saturday, November 8th. The Goldman Sachs Group reduced their price objective on shares of Axon Enterprise from $940.00 to $800.00 and set a “buy” rating for the company in a report on Wednesday, November 5th. Weiss Ratings restated a “hold (c-)” rating on shares of Axon Enterprise in a report on Monday, December 29th. Morgan Stanley dropped their price target on shares of Axon Enterprise from $760.00 to $713.00 and set an “overweight” rating on the stock in a research report on Wednesday, December 17th. Finally, Barclays lowered their price objective on Axon Enterprise from $861.00 to $702.00 and set an “overweight” rating for the company in a research note on Thursday, November 6th. Fifteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $786.43.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.